Chronic effects of enalapril and amlodipine on cardiac remodeling in cardiomyopathic hamster hearts

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 2, 1998, Pages 248-259

  Watanabe, Masashi ^a   Kawaguchi, Hideaki ^a   Onozuka, Hisao ^a   Mikami, Taisei ^b   Urasawa, Kazushi ^a   Okamoto, Hiroshi ^a   Watanabe, Satoshi ^a   Abe, Kazuhiro ^a   Kitabatake, Akira ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Collagen; Dilated cardiomyopathic hamster; Gene expression; Loss of myocytes; Phospholamban; Ryanodine receptor

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; MESSENGER RNA; PHOSPHOLAMBAN; RYANODINE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEART DILATATION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HISTOLOGY; LONG TERM CARE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SYRIAN HAMSTER;

AMLODIPINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BODY WEIGHT; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM-BINDING PROTEINS; CARDIOMYOPATHIES; CRICETINAE; DISEASE MODELS, ANIMAL; ENALAPRIL; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEART; MALE; MYOCARDIUM; RATS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 0031853483     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199808000-00012     Document Type: Article

References (35)

1. Sen S, Bumpus FM. Collagen synthesis in development and reversal of cardiac hypertrophy in spontaneously hypertensive rats. Am J Cardiol 1979;44:954-8.
2. Brilla CG, Janicki JS, Weber KT. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991;83:1771-9.
3. Baker KM, Aceto JF. Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol 1990;259:H610-8.
4. Packer M, O'Connor CM, Ghali JK, et al., for the Prospective Randomized Amlodipine Survival Evaluation study group. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996;335:1107-14.
5. Bajusz E. Hereditary cardiomyopathy: a new disease model. Am Heart J 1969;77:686-96.
6. Roberds SL, Ervasti JM, Anderson RD, et al. Disruption of the dystrophin-glycoprotein complex in the cardiomyopathic hamster. J Biol Chem 1993;268:11496-9.
7. Homburger F, Baker JR, Nixon CW, Whitney R. Primary generalized polymyopathy and cardiac necrosis in an inbred line of Syrian hamsters. Med Exp 1962;6:339-45.
8. Bajusz E, Baker JR, Nixon CW, Homburger F. Spontaneous hereditary myocardial degeneration and congestive heart failure in a strain of Syrian hamsters. Ann N Y Acad Sci 1969;156:105-29.
9. Strobeck JE, Factor SM, Bhan A, et al. Hereditary and acquired cardiomyopathies in experimental animals: mechanical, biochemical, and structural features. Ann N Y Acad Sci 1979;317:59-88.
10. Nayler WG. The effect of amlodipine on hypertension-induced cardiac hypertrophy and reperfusion-induced calcium overload. J Cardiovasc Pharmacol 1988;12(suppl 7):S41-4.
11. Mansoor MA, Honda M, Kuramochi T, Tanaka K, Morioka S. Takabatake T. Effects of ACE inhibition and beta-blockade on collagen remodelling in the heart of BIO14.6 hamsters. Clin Exp Pharmacol Physiol 1996;23:43-9.
12. Nascimben L. Friedrich J, Liao R, Pauletto P, Pessina CA, Ingwall SJ. Enalapril treatment increases cardiac performance and energy reserve via the creatine kinase reaction in myocardium of Syrian myopathic hamsters with advanced heart failure. Circulation 1995;91:1824-33.
13. Litwin SE, Katz SE, Weinberg EO, Lorell BH, Aurigemma GP, Douglas PS. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy: chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation 1995;91:2642-54.
14. Crawford MH, Grant D. O'Rourke RA, Starling MR, Groves BM. Accuracy and reproducibility of new M-mode echocardiographic recommendations for measuring left ventricular dimensions. Circulation 1980;61:137-42.
15. Sano Y. Histological technics: theoretical and applied. Tokyo: Nanzando, 1976:1-868.
16. Goldner J. A modification of the Masson trichrome technique for routine laboratory purpose. Am J Pathol 1938;14:237-43.
17. Gundersen HJG, Jensen EB. The efficiency of systematic sampling in stereology and its prediction. J Microsc 1987;147:229-63.
18. Cruz-Ovie LM. Systematic sampling in stereology. Bull Intern Statist lnst 1993;55:451-68.
19. Roberts N, Cruz-Ovie LM, Bourne M, Herfkens RJ, Karwoski RA, Whitehouse H. Analysis of cardiac function by MRI and stereology. J Microsc 1997;187:31-42.
20. Okada H, Kawaguchi H, Kudo T, et al. Alteration of extracellular matrix in dilated cardiomyopathic hamster heart. Mol Cell Biochem 1996;156:9-15.
21. Weibel ER. Stereological method. Vol. 1 : practical methods for biological morphometry. New York: Academic, 1979.
22. Weibel ER, Gromez DM. A principle for counting tissue structures on random sections. J Appl Physiol 1962;17:343-8.
23. Cruz-Ovie LM, Weibel ER. Recent Stereological methods for cell biology: a brief survey. Am J Physiol 1990;258:L148-56.
24. Nakai J, Imagawa T, Hakamata Y, Shigekawa M, Takeshima H, Numa S. Primary structure and functional expression from cDNA of the cardiac ryanodine receptor/calcium release channel. FEBS Lett 1990;271:169-77.
25. 2+-ATPase and phospholamban mRNA during rat heart development. Circ Res 1995;76:616-25.
26. Alwine JC, Kemp DJ, Stark GR. Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes. Proc Natl Acad Sci U S A 1977;74:5350-4.
27. Kawaguchi H, Kitabatake A. Renin-angiotensin system in failing heart. J Mol Cell Cardiol 1995;27:201-9.
28. Factor SM, Minase T, Cho S, Dominitz R, Sonnenblick EH. Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis. Circulation 1982;66: 342-54.
29. Jasmin G, Solymoss B. Prevention of hereditary cardiomyopathy in the hamster by verapamil and other agents. Proc Soc Exp Biol Med 1975;149:193-8.
30. Yamashita T, Kobayashi A, Yamazaki N, Miura K, Shirasawa H. Effects of L-carnitine and verapamil on myocardial camitine concentration and histopathology of Syrian hamster BIO14.6. Cardiovasc Res 1986;20:614-20.
31. Kobayashi A, Yamashita T, Kaneko M, Nishiyama T, Hayashi H, Yamazaki N. Effects of verapamil on experimental cardiomyopathy in the BIO14.6 Syrian hamster. J Am Coll Cardiol 1987;10:1128-34.
32. Factor SM, Cho S, Scheuer J, Sonnenblick EH, Malhotra A. Prevention of hereditary cardiomyopathy in the Syrian hamster with chronic verapamil therapy. J Am Coll Cardiol 1988;12:1599-604.
33. Jasmin G, Proshek L. Calcium and myocardial cell injury: an appraisal in the cardiomyopathic hamster. Can J Physiol Pharmacol 1984;62:891-8.
34. Sano H, Okada H, Kawaguchi H, Yasuda H. Increased angiotensin II stimulated collagen synthesis in cultured cardiac fibroblasts from spontaneously hypertensive rats. Circulation 1991;84(supple II):II-48.
35. 2+ pumps in heart and diaphragm of cardiomyopathic hamster: effects of perindopril. Am J Physiol 1995:H1947-53.